APGE
Price
$32.35
Change
-$2.64 (-7.55%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
2.03B
45 days until earnings call
RIGL
Price
$17.23
Change
-$0.43 (-2.43%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
315.73M
Ad is loading...

APGE vs RIGL

Header iconAPGE vs RIGL Comparison
Open Charts APGE vs RIGLBanner chart's image
Apogee Therapeutics
Price$32.35
Change-$2.64 (-7.55%)
Volume$19.09K
Capitalization2.03B
Rigel Pharmaceuticals
Price$17.23
Change-$0.43 (-2.43%)
Volume$2.95K
Capitalization315.73M
APGE vs RIGL Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. RIGL commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and RIGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (APGE: $34.99 vs. RIGL: $17.66)
Brand notoriety: APGE and RIGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 108% vs. RIGL: 76%
Market capitalization -- APGE: $2.03B vs. RIGL: $315.73M
APGE [@Biotechnology] is valued at $2.03B. RIGL’s [@Biotechnology] market capitalization is $315.73M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileRIGL’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • RIGL’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than RIGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 4 TA indicator(s) are bullish while RIGL’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 4 bullish, 6 bearish.
  • RIGL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both APGE and RIGL are a bad buy in the short-term.

Price Growth

APGE (@Biotechnology) experienced а -10.85% price change this week, while RIGL (@Biotechnology) price change was -4.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.31%. For the same industry, the average monthly price growth was -17.16%, and the average quarterly price growth was -18.95%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

RIGL is expected to report earnings on Aug 06, 2024.

Industries' Descriptions

@Biotechnology (-11.31% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.03B) has a higher market cap than RIGL($316M). RIGL YTD gains are higher at: 4.964 vs. APGE (-22.759). RIGL has higher annual earnings (EBITDA): 28.5M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. RIGL (77.3M). APGE has less debt than RIGL: APGE (11.8M) vs RIGL (60M). RIGL has higher revenues than APGE: RIGL (179M) vs APGE (0).
APGERIGLAPGE / RIGL
Capitalization2.03B316M642%
EBITDA-216.68M28.5M-760%
Gain YTD-22.7594.964-458%
P/E RatioN/A17.85-
Revenue0179M-
Total Cash521M77.3M674%
Total Debt11.8M60M20%
FUNDAMENTALS RATINGS
RIGL: Fundamental Ratings
RIGL
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
93
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
54
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGERIGL
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 19 days ago
84%
Bullish Trend 19 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RIGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DGOYX40.99N/A
N/A
Davis Opportunity Y
LGGAX62.69N/A
N/A
ClearBridge International Growth A
CMGVX26.01N/A
N/A
Columbia Select Mid Cap Gro Fd I2
VSQYX16.05N/A
N/A
Invesco MSCI World SRI Index Y
DILYX13.19-0.37
-2.73%
Davis International Y

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-7.51%
SYRE - APGE
47%
Loosely correlated
-9.68%
INZY - APGE
47%
Loosely correlated
-5.49%
KYMR - APGE
46%
Loosely correlated
-10.13%
ELVN - APGE
46%
Loosely correlated
+0.86%
ATXS - APGE
45%
Loosely correlated
-6.70%
More